News

F. Hoffmann-La Roche Ltd: Roche presents new insights in Alzheimer's disease research across its diagnostics and pharmaceutical portfolios at AAIC
Trontinemab's Phase Ib/IIa Brainshuttle AD study continues to show rapid and robust clearance of amyloid plaques, with 91% becoming amyloid PET negative and ARIA-E remaining Design of the Phase III TR ...
The Express Tribune on MSN17h
The end of an era?
Back in the mid-2010s, when the idea of 'binge-watching' was still novel, you could impress someone you met at a party by saying you watched Black Mirror. The streaming service Netflix had already ...
Organic Authority on MSN2h
Flexitarian Meal Plan Secrets That Actually Work (From Someone Who’s Been There)
I used to be that person meal prepping identical chicken and broccoli containers every Sunday, convinced that consistency was ...